Logical Biological recognized as one of ‘Europe’s fastest-growing companies’ due to customer centric approach and quality commitment

Logical Biological specialise in providing human serum, plasma, swabs, tissues, PBMCs and other biological specimens for diagnostics and therapeutic research and development.

Breakthrough research reveals how to target malignant DNA in aggressive cancers

Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the

November 9, 2024

DPI-125 by DMK Pharmaceuticals for Opium (Opioid) Addiction: Likelihood of Approval

DPI-125 is under clinical development by DMK Pharmaceuticals and currently in Phase I for Opium (Opioid) Addiction.

July 5, 2024

Cancer Vaccines’ Emergence; More Focus on Side Effects; A Nudge for Exercise

The backstory of cancer vaccines’ rise to clinical relevance. (MIT Technology Review) Adding an immune system booster to a personalized cancer vaccine enhanced immune response

May 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.